Category: Baxano SurgicalSyndicate content

Baxano Surgical files for bankruptcy, CFO steps down

November 13, 2014 by Brad Perriello

Baxano Surgical says it's filed for Chapter 11 bankruptcy protection and announces the resignation of CFO Timothy Shannon, 2 months after hiring an investment bank to examine 'strategic alternatives.'

Baxano Surgical files for bankruptcy, CFO steps down

TriVascular Tech recall of stent grafts may drag down full-year revenues | Medtech Wall Street news for the week of September 22, 2014

September 25, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: TriVascular Tech's stent graft recall could hurt the bottom line; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules; Baxano puts itself on the auction block; Philips to carve out lighting biz, merger healthcare & consumer units

TriVascular Tech's stent graft recall could hurt the bottom line

September 19, 2014 by Arezu Sarvestani

TriVascular Tech's stent graft recall could hurt the bottom line

Baxano puts itself on the auction block

September 18, 2014 by Brad Perriello

Baxano Surgical said it's hired an investment advisor to explore "strategic alternatives," corporate shorthand for putting itself on the auction block.

Baxano puts itself on the auction block

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FTC wants more data on MDT-COV deal | Medtech Wall Street news for the week of August 11, 2014

August 14, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; Greatbatch acquires Uruguay's CCC Medical Devices; T2 Biosystems IPO raises $57M for MRI-based diagnostics; Strong Q4, $750M buyback give CareFusion a boost; Baxano: Strong Q2, new patents can't appease Wall Street

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried

August 7, 2014 by Arezu Sarvestani

Analyst report: Dems can't stop Medtronic-Covidien merger

Baxano: Strong Q2, new patents can't appease Wall Street

August 8, 2014 by Arezu Sarvestani

Baxano's stock drops 25% after the company reports a 20% increase in sales during its 2nd quarter and the issuance of 2 new patents covering its minimally invasive spinal devices.

Baxano: Strong Q2, $10M raise, new patents and clinical trial can't appease Wall Street

Baxano Surgical (NSDQ:BAXS) just can't seem to do right by Wall Street.

Spine: Baxano Surgical closes $10M private placement

April 24, 2014 by Arezu Sarvestani

Baxano Surgical puts a ribbon on a private placement funding round after raising $10 million from unnamed investors.

Spine: Baxano Surgical closes $10M private placement
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp